ImmuneOnco Biopharmaceuticals (Shanghai) Inc 2025 Sustainability Report
Company: ImmuneOnco Biopharmaceuticals (Shanghai) Inc
Sector: Manufacturing
Country: China
Year: 2025
Type: Sustainability Report
Pages: 49
The report describes ImmuneOnco's ESG governance, including Board oversight and an ESG Working Group. It reports 2025 total GHG emissions of 2,108.69 tCO2e, energy consumption of 3,157.44 kWh in '000s, and water consumption of 4,078 tonnes. The workforce reached 202 employees, including 130 female employees. The company also highlights compliance management, climate-risk processes, employee-care initiatives, and community environmental activities.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.